NELSON MULLINS RILEY & SCARBOROUGH

Lobbying for ANBEX, INC. · Pharmaceutical Manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $15,000.00 income · posted Mar 31, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Stockpile potassium iodide to counteract effects of nuclear radiation.

Energy/Nuclear

The utilization of potassium iodide to protect against nuclear radiation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.